Key points are not available for this paper at this time.
in the transgenic mice, despite loss-of-function of NMDARs. Overall, we disentangle a GluN1 variant's receptor-level effects and its dendritic impact to treat seizures effectively.
Venkatesan et al. (Mon,) studied this question.